Form 4: Seacoast Banking Corp Executive Juliette Kleffel Reports Stock Transactions
SEC Form 4 Filing
Juliette Kleffel, EVP and Chief Banking Officer of Seacoast Banking Corporation of Florida, reports the acquisition and disposal of common stock and derivative securities.
Summary
- Juliette Kleffel, an executive at Seacoast Banking Corporation of Florida, filed a Form 4 detailing changes in beneficial ownership.
- On April 1, 2024, Kleffel disposed of 190 shares, 164 shares, and 379 shares of common stock at a price of $24.76.
- Also on April 1, 2024, Kleffel acquired 18,527 shares of common stock at $24.76.
- Kleffel directly owns 51,528 shares of common stock.
- Kleffel also owns rights to buy 12,635 shares of common stock at $31.15, exercisable from April 2, 2028, and 14,831 shares at $28.69, exercisable from April 3, 2027.
- These rights were granted pursuant to Seacoast Banking Corporation of Florida's 2013 Incentive Plan and vest over 3 years subject to continuous employment and the company's banking subsidiary meeting certain capital requirements.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It reflects standard executive compensation practices.
Positives
- The acquisition of 18,527 shares by an executive could be seen as a positive signal.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of the restricted stock awards and stock options suggest continued employment is expected.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, bonus, stock options, and restricted stock awards.
- Vesting schedules for stock options and restricted stock are common practice to incentivize long-term performance and retention.
- The specific terms of these awards, such as the vesting period and exercise price, are typically benchmarked against industry peers to ensure competitiveness.
Stakeholder Impact
- Shareholders can use this information to understand executive compensation and alignment with company performance.
- Employees may be interested in the terms of the stock options and restricted stock awards as they relate to their own compensation.
Key Dates
| Date | Description |
|---|---|
| 04/01/2021 | Date of grant for an unvested time-based restricted stock award that vests over 3 years. |
| 04/01/2022 | Date of grant for an unvested time-based restricted stock award that vests over 3 years. |
| 04/01/2023 | Date of grant for an unvested time-based restricted stock award that vests over 3 years. |
| 04/01/2024 | Date of stock disposal and acquisition transactions; Date of grant for an unvested time-based restricted stock award that vests over 3 years. |
| 04/02/2028 | Date from which rights to buy 12,635 shares of common stock at $31.15 become exercisable. |
| 04/03/2027 | Date from which rights to buy 14,831 shares of common stock at $28.69 become exercisable. |
| 04/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.